NN
Nataraj Nanjundappa
About Nataraj Nanjundappa
Data last updated:
Nataraj Nanjundappa is a Director at Invision Medi Sciences Private Limited (since 2013) and Director at Invision Pharma Limited (since 2018). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹21.73 Cr; the largest is Invision Medi Sciences Private Limited at ₹18.08 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Invision Medi Sciences Private Limited U24234KA2011PTC057213 | Director | 12 Oct 2013 | 2011 | ₹18.08 Cr (FY 2025) | Active |
 Invision Pharma Limited U24304KA2018PLC113264 | Director | 21 May 2018 | 2018 | ₹3.66 Cr (FY 2024) | Active |
Board colleagues of Nataraj Nanjundappa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chirag Mukeshkumar | 07481778 | Invision Medi Sciences Private Limited , Invision Pharma Limited | Director |
| Mukeshkumar | 01744803 | Invision Medi Sciences Private Limited , Invision Pharma Limited | Managing Director |
| Seema | 03381777 | Invision Medi Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nataraj Nanjundappa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nataraj Nanjundappa
Nataraj Nanjundappa currently holds 2 directorships: Invision Medi Sciences Private Limited (Director, since 12 Oct 2013, revenue ₹18.08 Cr (FY 2025)); Invision Pharma Limited (Director, since 21 May 2018, revenue ₹3.66 Cr (FY 2024)).
Nataraj Nanjundappa was first appointed on 12 Oct 2013 as Director at Invision Medi Sciences Private Limited. The most recent appointment on record is 21 May 2018 at Invision Pharma Limited.
The 2 current companies of Nataraj Nanjundappa that report revenue have a combined latest revenue of ₹21.73 Cr: Invision Medi Sciences Private Limited ₹18.08 Cr (FY 2025); Invision Pharma Limited ₹3.66 Cr (FY 2024).
The current boards of Nataraj Nanjundappa's companies include Chirag Mukeshkumar (Invision Medi Sciences Private Limited), Mukeshkumar (Invision Medi Sciences Private Limited), Seema (Invision Medi Sciences Private Limited).